Johnson & Johnson JNJ
NYSE JNJ
$269.99 -0.22 (-0.08%)
At close: Sep 18, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Dividends Paid - Common (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Dividends Paid - Common came in at $3.2 billion in Q2 2026, up 3.13% year-over-year from $3.1 billion in Q2 2025, and up 3.07% quarter-over-quarter from $3.1 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Dividends Paid - Common (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Dividends Paid - Common across 18 years of filings, most recently posting $3.2 billion for Q2 2026.

  • In Q2 2026, Dividends Paid - Common rose 3.13% year-over-year to $3.2 billion; the TTM figure through Jun 2026 stood at $12.6 billion (up 4.42% YoY), while the FY2025 annual figure was $12.4 billion, up 4.72% from the prior year.
  • Dividends Paid - Common came in at $3.2 billion for Q2 2026 at Johnson & Johnson, up from $3.1 billion in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $3.4 billion in Q1 2023 to a low of $2.8 billion in Q2 2022.
  • Average Dividends Paid - Common over 5 years is $3.0 billion, with a median of $3.0 billion recorded in 2024.
  • The largest YoY upside for Dividends Paid - Common was 5.56% in 2023 against a maximum downside of 16.74% in 2023.
  • Over 5 years, Dividends Paid - Common stood at $2.8 billion in 2022, then advanced by 2.8% to $2.9 billion in 2023, then gained by 4.15% to $3.0 billion in 2024, then rose by 4.93% to $3.1 billion in 2025, then rose by 3.07% to $3.2 billion in 2026.
  • Per Business Quant data, the three most recent Dividends Paid - Common figures were $3.2 billion in Q2 2026, $3.1 billion in Q1 2026, and $3.1 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 3.23 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 3.07 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 2.14 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -2.87 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 2.45 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 1.29 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 6.09 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 3.23 Bn
Mar 29, 2026 3.13 Bn
Dec 28, 2025 3.13 Bn
Sep 28, 2025 3.13 Bn
Jun 29, 2025 3.13 Bn
Mar 30, 2025 2.99 Bn
Dec 29, 2024 2.98 Bn
Sep 29, 2024 2.99 Bn
Jun 30, 2024 2.99 Bn
Mar 31, 2024 2.87 Bn
Dec 31, 2023 2.87 Bn
Oct 1, 2023 2.87 Bn
Jul 2, 2023 3.09 Bn
Apr 2, 2023 2.94 Bn
Jan 1, 2023 3.44 Bn
Apr 3, 2022 2.79 Bn
Oct 3, 2021 2.79 Bn
Jul 4, 2021 2.79 Bn
Apr 4, 2021 2.66 Bn
Jan 3, 2021 2.66 Bn